Posaconazole Intravenous (IV) Solution bulk supplier for pharma manufacturers

Posaconazole Intravenous (Iv) Solution 300 mg/100 mL Suppliers & Bulk Manufacturers

Available Forms: Intravenous (IV) solution

Available Strengths: 300 mg/100 mL

Reference Brands: Noxafil(US & EU)

Posaconazole IV inhibits fungal cytochrome P450 14α-demethylase, disrupting ergosterol synthesis and fungal cell membrane formation. It provides broad-spectrum antifungal activity, rapid systemic absorption, and excellent tissue penetration. Benefits include effective treatment of invasive fungal infections, reliable intravenous delivery, and high bioavailability, crucial for managing severe fungal diseases.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Posaconazole IV is approved in the EU and US for treating invasive fungal infections. In the EU, MSD’s Noxafil IV is regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval is based on extensive clinical data, biosimilarity assessments, and ongoing pharmacovigilance. Both regions require detailed regulatory dossiers for initial approval and continued safety monitoring. For expert assistance with pharmaceutical dossiers, regulatory submissions, and compliance, visit PharmaTradz. We support efficient market access for posaconazole IV formulations, ensuring adherence to European and American standards for safe, effective antifungal therapy.

Posaconazole Intravenous (Iv) Solution — third party manufacturing & bulk supply

Posaconazole Intravenous (Iv) Solution 300 mg/100 mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Posaconazole Intravenous (Iv) Solution is supplied as Intravenous (IV) solution — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Posaconazole Intravenous (Iv) Solution listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Posaconazole Intravenous (Iv) Solution →

Back to Listing

Frequently Asked Questions

Posaconazole is used to prevent and treat serious fungal infections, particularly in immunocompromised patients such as those with hematologic malignancies or stem-cell transplants. It is effective against invasive aspergillosis, mucormycosis, and infections caused by Candida species. It is commonly used when patients cannot tolerate or do not respond to other antifungal therapies.

Posaconazole contains the active triazole antifungal compound posaconazole. The formulation includes pharmaceutical excipients that enhance absorption and maintain stability, depending on the dosage form used.

The main trade name for posaconazole is Noxafil, recognized in the USA, EU, UK, and many international markets.

Noxafil (posaconazole) is manufactured by Merck & Co. Generic versions may also be produced by other GMP-certified pharmaceutical companies in different regions.

The generic name is posaconazole.

The primary brand name is Noxafil.

Posaconazole is manufactured in Merck’s regulated facilities located in the USA and Europe, along with various GMP-approved global manufacturers producing generic posaconazole for international distribution.